-
-
-
-
-
-
-
Meridian Bioscience Announces Preliminary Results for Fiscal 2022 Third Quarter
-
-
-
-
-
-
-
Meridian Bioscience (VIVO) Tops Q1 EPS by 10c; Offers 2022 Guidance
-
-
-
-
-
-
-
Meridian Bioscience Reports Strong Fourth Quarter And Record Full-Year Fiscal 2021 Operating Results And Provides Fiscal 2022 Guidance
-
-
-
-
-
-
-
Meridian Bioscience to Hold Third Quarter Fiscal 2021 Financial Results Conference Call on August 6, 2021
-
-
-
-
-
-
-
Meridian Bioscience Reports Strong Growth in Net Revenues and EPS in Second Quarter Fiscal 2021
-
-
-
-
-
-
-
Meridian Bioscience Provides a Further Update on the Revogene® SARS-CoV-2 EUA Submission
-
-
-
-
-
-
-
Meridian Bioscience to Hold First Quarter Fiscal 2021 Financial Results Conference Call on February 5, 2021
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

